SCIENTURE HOLDINGS, INC. Net Cash Provided by (Used in) Discontinued Operations
SCIENTURE HOLDINGS, INC. (SCNX) reported Net Cash Provided by (Used in) Discontinued Operations of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-02.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInDiscontinuedOperations · last filed 2018-03-02
- SCIENTURE HOLDINGS, INC. net cash provided by (used in) discontinued operations for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- SCIENTURE HOLDINGS, INC. net cash provided by (used in) discontinued operations for the quarter ending 2017-09-30 was $0.00.
- SCIENTURE HOLDINGS, INC. net cash provided by (used in) discontinued operations for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
- SCIENTURE HOLDINGS, INC. net cash provided by (used in) discontinued operations for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- SCIENTURE HOLDINGS, INC. net cash provided by (used in) discontinued operations for fiscal 2017 was $0.00.
- SCIENTURE HOLDINGS, INC. net cash provided by (used in) discontinued operations for fiscal 2016 was -$181.89K.
- SCIENTURE HOLDINGS, INC. net cash provided by (used in) discontinued operations for fiscal 2015 was -$1.11M.
| Period end | Net Cash Provided by (Used in) Discontinued Operations 3 month | Net Cash Provided by (Used in) Discontinued Operations 6 month | Net Cash Provided by (Used in) Discontinued Operations 9 month | Net Cash Provided by (Used in) Discontinued Operations 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | $0.00 derived: sum of 2 quarters · filed 2018-03-02 | $0.00 derived: sum of 3 quarters · filed 2018-03-02 | $0.00 10-K · filed 2018-03-02 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $0.00 derived: sum of 2 quarters · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 | $72.59K derived: sum of 4 quarters · filed 2018-03-02 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $0.00 10-Q · filed 2017-08-04 | $72.59K derived: sum of 3 quarters · filed 2018-03-02 | -$320.98K derived: sum of 4 quarters · filed 2018-03-02 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-15 | $72.59K derived: sum of 2 quarters · filed 2018-03-02 | -$320.98K derived: sum of 3 quarters · filed 2018-03-02 | -$196.36K derived: sum of 4 quarters · filed 2018-03-02 |
| 2016-12-31 | $72.59K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | -$320.98K derived: sum of 2 quarters · filed 2018-03-02 | -$196.36K derived: sum of 3 quarters · filed 2018-03-02 | -$181.89K 10-K · filed 2018-03-02 |
| 2016-09-30 | -$393.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$268.96K derived: sum of 2 quarters · filed 2017-11-07 | -$254.48K 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $124.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $139.09K 10-Q · filed 2017-08-04 | ||
| 2016-03-31 | $14.47K 10-Q · filed 2017-05-15 | |||
| 2015-12-31 | -$1.11M 10-K · filed 2017-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |